PGEN stock forecast based on Fibonacci retracements marks $2.12 as a key upside target, with $1.62 as critical downside protection in swing strategies. Ultimately the future is most important . You can access this free report on analyst forecasts for the company . We have seen 62 institutional investors add shares of $PGEN stock to their portfolio, and 60 decrease their positions in their most recent quarter. Investors tracking the PGEN stock forecast note that trading volume has picked up in the past two weeks, coinciding with positive industry news in gene therapy. Analysts are watching RSI levels nearing 55, which signals mild bullish momentum if institutional buying continues.